Trending Oncology CME/CE

New Directions in the Management of Recurrent Ovarian Cancer: Focus on PARP Inhibitors

New Directions in the Management of Recurrent Ovarian Cancer: Focus on PARP Inhibitors

This activity will bring a leading clinical investigator to your cancer center to discuss emerging data on PARP inhibitors that can rationally inform the management of ovarian cancer. Enroll your institution today!

Format: CME-certified visiting faculty lecture series

Learn more

Challenges and Opportunities in Metastatic Castration-Resistant Prostate Cancer: A CME/CE/CPE-Certified VA/DoD Meeting Series

Challenges and Opportunities in Metastatic Castration-Resistant Prostate Cancer: A CME/CE/CPE-Certified VA/DoD Meeting Series

This live activity will bring a leading clinical investigator to your VA/DoD medical center to discuss emerging data on treatment selection, resistance, and response in CRPC. Book a meeting today!

Format: CME/CE/CPE-certified visiting faculty meeting series

Learn more

Optimizing Management of Carcinoid Syndrome in Patients With Neuroendocrine Tumors

Optimizing Management of Carcinoid Syndrome in Patients With Neuroendocrine Tumors

In this case-based activity, Pamela Ryan, RN, BSN from Ochsner Medical Center and Donna Williams, RN from Stanford Medicine discuss signs and symptoms of carcinoid syndrome in patients with neuroendocrine tumors and the application of supportive care strategies to provide symptom relief. Participate from the comfort of your home or office!

Format: CE-certified online activity

Learn more

Current Trends and Future Directions in Targeted Therapies for Advanced Renal Cell Carcinoma

Current Trends and Future Directions in Targeted Therapies for Advanced Renal Cell Carcinoma

This activity will bring a leading clinical investigator to your cancer center to discuss emerging data on targeted therapies in the treatment of patients with advanced renal cell carcinoma. Enroll your institution today.

Format: CME-certified visiting faculty meeting series

Learn more

Preventing and Mitigating Chemotherapy-Induced Nausea and Vomiting in High-Risk Patients

Preventing and Mitigating Chemotherapy-Induced Nausea and Vomiting in High-Risk Patients

In this case-based activity, Rebecca Clark-Snow, RN, BSN, OCN® and Una T. Hopkins, DNP discuss CINV risk assessment, emetic risk, antiemetic regimens, and self report in high-risk patients. Participate from the comfort of your home or office.

Format: CE-certified online activity

Learn more

Defining Personalized Care Plans in Metastatic Castration-Resistant Prostate Cancer

Defining Personalized Care Plans in Metastatic Castration-Resistant Prostate Cancer

Watch this CME/CE-certified discussion with Tanya Dorff, MD from the Keck School of Medicine as she discusses progress in our understanding of predictive/prognostic markers in advanced prostate cancer as well as optimizing treatment sequencing and response assessment. Participate from the comfort of your home or office.

Format: CME/CE-certified online activity

Learn more

Nursing Strategies to Optimize Treatment Experiences in Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer

Nursing Strategies to Optimize Treatment Experiences in Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer

This expert-led live meeting will discuss individualized treatment planning for patients with MBC. Participants will learn about CDK4/6 inhibitor safety profiles and the use of supportive care planning to mitigate AEs. Book this meeting at your institution now!

Format: CE-certified visiting faculty meeting series

Learn more

Optimizing the Treatment of Metastatic Merkel Cell Carcinoma With Immune Checkpoint Inhibitors

Optimizing the Treatment of Metastatic Merkel Cell Carcinoma With Immune Checkpoint Inhibitors

Immunotherapy is disrupting cancer care! This activity will bring a clinical expert to your cancer center to share insights into how immune checkpoint inhibitors can enhance the survival outcomes of patients with metastatic MCC. Enroll your institution now.

Format: CME/CE-certified visiting faculty meeting series

Learn more

Selecting Optimal Antiangiogenic Strategies for Patients With Hepatocellular Carcinoma

Selecting Optimal Antiangiogenic Strategies for Patients With Hepatocellular Carcinoma

This activity features an expert-led, case-based discussion with Thomas A. Abrams, MD from Dana-Farber Cancer Institute and Harvard Medical School on evolving antiangiogenic strategies with multikinase inhibitors in first- and second-line treatment of advanced HCC. Participate from the comfort of your home or office.

Format: CME/CE-certified online activity

Learn more

Optimizing Nursing Management of Hepatic Veno-Occlusive Disease

Optimizing Nursing Management of Hepatic Veno-Occlusive Disease

Veno-occlusive disease, also known as sinusoidal obstruction syndrome, is a potentially life-threatening complication of hematopoietic stem cell transplant. Watch this expert-led discussion on nursing management best practices.

Format: CE-certified online activity

Learn more

Optimizing Management of Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Optimizing Management of Relapsed/Refractory Diffuse Large B-Cell Lymphoma

This activity will bring a leading clinical investigator to your cancer center to discuss and debate evidence-based best practices in the management of relapsed/refractory diffuse large B-cell lymphoma. Request a meeting for your institution today!

Format: CME-certified visiting faculty meeting series

Learn more

Optimizing the Treatment of Hematologic Malignancies With Hematopoietic Stem Cell Transplant

Optimizing the Treatment of Hematologic Malignancies With Hematopoietic Stem Cell Transplant

This activity will bring a leading clinical investigator to your hematology/oncology fellowship program to discuss emerging data that can rationally inform the management of hematologic malignancies with stem cell transplant. Enroll your institution today!

Format: CME-certified visiting professor lecture series

Learn more

Selecting Optimal Therapeutic Strategies for Patients With Differentiated and Medullary Thyroid Cancer

Selecting Optimal Therapeutic Strategies for Patients With Differentiated and Medullary Thyroid Cancer

In this case-based activity, leading clinical investigator Jochen Lorch, MD, MS from Dana-Farber Cancer Institute will share insights into evidence-based personalized care planning for patients with differentiated and medullary thyroid cancer. Participate from the comfort of your home or office.

Format: CME-certified online activity

Learn more

Clinical Advances and Research Progress in Chronic Lymphocytic Leukemia

Clinical Advances and Research Progress in Chronic Lymphocytic Leukemia

This activity will bring a leading clinical investigator to your hematology/oncology fellowship program to examine current challenges, new opportunities, and future directions in the management of CLL. Enroll your institution today!

Format: CME-certified visiting professor lecture series

Learn more

Appraisal of Recent Progress in Metastatic Castration-Resistant Prostate Cancer: Current Trends and Future Directions

Appraisal of Recent Progress in Metastatic Castration-Resistant Prostate Cancer: Current Trends and Future Directions

In this case-based activity, leading clinical investigator Oliver Sartor, MD examines recent developments and best practices in treatment selection and supportive care planning for patients with metastatic castration-resistent prostate cancer.

Format: CME-certified online activity

Learn more

Resources

News & Perspectives
More